Omega-3 (EPA+DHA) index risk in Serum or Plasma

Omega-3 index risk SFr SerPl

Definition

The omega-3 index, defined as eicosapentaenoate (EPA)+ docosahexaenoate (DHA)/Fatty acids.C14-C24, is a clinically useful measurement for evaluating blood levels of EPA and DHA. There are many health benefits from maintaining a good level of omega-3 fatty acids including reduced inflammation, risk of heart disease, cancer, arthritis, and many more. Deficiency in omega-3 fatty acids can result in fatigue, poor memory, dry skin, heart problems, mood swings, and poor circulation.[https://www.umm.edu/health/medical/altmed/supplement/omega3-fatty-acids] There have been a number of clinical trials to determine the effect of omega-3 supplementation based on a 1g/day dose of EPA, which successfully increased the total omega-3 level to >5% for 84% of the study participants. The remaining 16% had levels below 5%, which is the threshold at which significant reduction in sudden coronary death reduction is evident. The variability in the blood levels of omega-3 in patients who received the same supplemental dose of omega-3 has been attributed to genetic differences in fatty acid metabolism, body weight, baseline omega-3 level, age, gender, and physical activity.[PMID: 25285179] This test measures the level of omega-3 as a percent of total fatty acids, and the result of that index is associated with a high, moderate, or low risk of cardiovascular disease.

Acd; Acid; C20:5w3; C22:6w3; Cervonate; Cervonic acid; Chemistry; DHA; Docosahexaenoic acid; Eicosapentaenoic acid; EPA; EPA+DHA; Fatty acid; Icosapentaenoate; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lipid; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Timnodonate; Timnodonic Acid